questionsmedicales.fr
Maladies de la peau et du tissu conjonctif
Maladies de la peau
Infections de la peau
Dermatoses parasitaires
Leishmaniose
Leishmaniose cutanée
Leishmaniose cutanée : Questions médicales fréquentes
Diagnostic
5
Leishmaniose cutanée
Diagnostic médical
Tests de laboratoire
Leishmaniose cutanée
Symptômes
Leishmaniose cutanée
Diagnostic différentiel
Leishmaniose cutanée
Épidémiologie
Leishmaniose cutanée
Symptômes
5
Symptômes
Leishmaniose cutanée
Douleur
Leishmaniose cutanée
Cicatrisation
Leishmaniose cutanée
Symptômes systémiques
Leishmaniose cutanée
Variabilité géographique
Leishmaniose cutanée
Prévention
5
Prévention
Leishmaniose cutanée
Moustiquaires
Leishmaniose cutanée
Vaccins
Leishmaniose cutanée
Prévention
Leishmaniose cutanée
Contrôle des vecteurs
Leishmaniose cutanée
Traitements
5
Traitement
Leishmaniose cutanée
Efficacité du traitement
Leishmaniose cutanée
Effets secondaires
Leishmaniose cutanée
Chirurgie
Leishmaniose cutanée
Prévention
Leishmaniose cutanée
Complications
5
Complications
Leishmaniose cutanée
Leishmaniose viscérale
Leishmaniose cutanée
Cicatrices
Leishmaniose cutanée
Infections secondaires
Leishmaniose cutanée
Santé mentale
Leishmaniose cutanée
Facteurs de risque
5
Facteurs de risque
Leishmaniose cutanée
Immunodépression
Leishmaniose cutanée
Voyage
Leishmaniose cutanée
Environnement
Leishmaniose cutanée
Population rurale
Leishmaniose cutanée
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Leishmaniose cutanée : Questions médicales les plus fréquentes",
"headline": "Leishmaniose cutanée : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Leishmaniose cutanée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-05",
"dateModified": "2026-04-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Leishmaniose cutanée"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Leishmaniose",
"url": "https://questionsmedicales.fr/mesh/D007896",
"about": {
"@type": "MedicalCondition",
"name": "Leishmaniose",
"code": {
"@type": "MedicalCode",
"code": "D007896",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.838.775.560"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Leishmaniose cutanée diffuse",
"alternateName": "Leishmaniasis, Diffuse Cutaneous",
"url": "https://questionsmedicales.fr/mesh/D016774",
"about": {
"@type": "MedicalCondition",
"name": "Leishmaniose cutanée diffuse",
"code": {
"@type": "MedicalCode",
"code": "D016774",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.838.775.560.400.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Leishmaniose cutanéomuqueuse",
"alternateName": "Leishmaniasis, Mucocutaneous",
"url": "https://questionsmedicales.fr/mesh/D007897",
"about": {
"@type": "MedicalCondition",
"name": "Leishmaniose cutanéomuqueuse",
"code": {
"@type": "MedicalCode",
"code": "D007897",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.838.775.560.400.385"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Leishmaniose cutanée",
"alternateName": "Leishmaniasis, Cutaneous",
"code": {
"@type": "MedicalCode",
"code": "D016773",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Nebiye Yentur Doni",
"url": "https://questionsmedicales.fr/author/Nebiye%20Yentur%20Doni",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Microbiology, Harran University Medical Faculty, Şanlıurfa 63000, Turkey."
}
},
{
"@type": "Person",
"name": "Ali Khamesipour",
"url": "https://questionsmedicales.fr/author/Ali%20Khamesipour",
"affiliation": {
"@type": "Organization",
"name": "Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "I Abadías-Granado",
"url": "https://questionsmedicales.fr/author/I%20Abad%C3%ADas-Granado",
"affiliation": {
"@type": "Organization",
"name": "Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, Spain. Electronic address: isabel.abadiasg@gmail.com."
}
},
{
"@type": "Person",
"name": "A Diago",
"url": "https://questionsmedicales.fr/author/A%20Diago",
"affiliation": {
"@type": "Organization",
"name": "Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, Spain."
}
},
{
"@type": "Person",
"name": "P A Cerro",
"url": "https://questionsmedicales.fr/author/P%20A%20Cerro",
"affiliation": {
"@type": "Organization",
"name": "Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Effects of cutaneous leishmaniasis on patients' quality of life.",
"datePublished": "2024-06-18",
"url": "https://questionsmedicales.fr/article/38890616",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12879-024-09518-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Complicated Cutaneous Leishmaniasis in a Patient under Combined Immunosuppression.",
"datePublished": "2023-10-13",
"url": "https://questionsmedicales.fr/article/37837360",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.20344/amp.19446"
}
},
{
"@type": "ScholarlyArticle",
"name": "Case Report: Extensive Facial Cutaneous Leishmaniasis in a Neonate.",
"datePublished": "2023-07-24",
"url": "https://questionsmedicales.fr/article/37487561",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4269/ajtmh.23-0177"
}
},
{
"@type": "ScholarlyArticle",
"name": "Spatial analysis of American cutaneous leishmaniasis in the state of Amazonas.",
"datePublished": "2024-04-19",
"url": "https://questionsmedicales.fr/article/38656046",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.11606/s1518-8787.2024058005662"
}
},
{
"@type": "ScholarlyArticle",
"name": "Metallic nanoparticles and treatment of cutaneous leishmaniasis: A systematic review.",
"datePublished": "2024-02-01",
"url": "https://questionsmedicales.fr/article/38364464",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jtemb.2024.127404"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de la peau et du tissu conjonctif",
"item": "https://questionsmedicales.fr/mesh/D017437"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies de la peau",
"item": "https://questionsmedicales.fr/mesh/D012871"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections de la peau",
"item": "https://questionsmedicales.fr/mesh/D012874"
},
{
"@type": "ListItem",
"position": 5,
"name": "Dermatoses parasitaires",
"item": "https://questionsmedicales.fr/mesh/D012876"
},
{
"@type": "ListItem",
"position": 6,
"name": "Leishmaniose",
"item": "https://questionsmedicales.fr/mesh/D007896"
},
{
"@type": "ListItem",
"position": 7,
"name": "Leishmaniose cutanée",
"item": "https://questionsmedicales.fr/mesh/D016773"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Leishmaniose cutanée - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Leishmaniose cutanée",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Leishmaniose cutanée",
"description": "Comment diagnostique-t-on la leishmaniose cutanée ?\nQuels tests sont utilisés pour confirmer la leishmaniose ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on confondre la leishmaniose avec d'autres maladies ?\nQuel rôle joue l'historique de voyage dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D016773#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Leishmaniose cutanée",
"description": "Quels sont les symptômes de la leishmaniose cutanée ?\nLes lésions sont-elles douloureuses ?\nLes lésions peuvent-elles cicatriser ?\nY a-t-il des symptômes systémiques associés ?\nLes symptômes varient-ils selon les régions ?",
"url": "https://questionsmedicales.fr/mesh/D016773#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Leishmaniose cutanée",
"description": "Comment prévenir la leishmaniose cutanée ?\nLes moustiquaires sont-elles efficaces ?\nLes vaccins contre la leishmaniose existent-ils ?\nLes traitements préventifs sont-ils disponibles ?\nComment réduire les habitats des phlébotomes ?",
"url": "https://questionsmedicales.fr/mesh/D016773#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Leishmaniose cutanée",
"description": "Quels traitements sont disponibles pour la leishmaniose cutanée ?\nLes traitements sont-ils efficaces ?\nY a-t-il des effets secondaires aux traitements ?\nLa chirurgie est-elle une option de traitement ?\nLes traitements préventifs existent-ils ?",
"url": "https://questionsmedicales.fr/mesh/D016773#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Leishmaniose cutanée",
"description": "Quelles complications peuvent survenir ?\nLa leishmaniose cutanée peut-elle évoluer vers une forme viscérale ?\nLes cicatrices sont-elles fréquentes après traitement ?\nLes infections secondaires sont-elles courantes ?\nY a-t-il des impacts psychologiques liés à la maladie ?",
"url": "https://questionsmedicales.fr/mesh/D016773#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Leishmaniose cutanée",
"description": "Quels sont les principaux facteurs de risque ?\nLes personnes immunodéprimées sont-elles plus à risque ?\nLes voyageurs sont-ils à risque ?\nLes conditions environnementales influencent-elles le risque ?\nLes populations rurales sont-elles plus touchées ?",
"url": "https://questionsmedicales.fr/mesh/D016773#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la leishmaniose cutanée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et des tests de laboratoire, comme la biopsie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer la leishmaniose ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'examen microscopique, la culture et les tests sérologiques."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques comme les lésions cutanées orientent le diagnostic."
}
},
{
"@type": "Question",
"name": "Peut-on confondre la leishmaniose avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec d'autres infections cutanées comme la tuberculose cutanée."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique de voyage dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un historique de voyage dans des zones endémiques est crucial pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la leishmaniose cutanée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des lésions cutanées, des ulcères et des nodules sur la peau."
}
},
{
"@type": "Question",
"name": "Les lésions sont-elles douloureuses ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les lésions peuvent être douloureuses ou asymptomatiques, selon le patient."
}
},
{
"@type": "Question",
"name": "Les lésions peuvent-elles cicatriser ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les lésions peuvent cicatriser, mais des cicatrices peuvent persister."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Généralement, la leishmaniose cutanée n'entraîne pas de symptômes systémiques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les régions ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la présentation clinique peut varier selon les espèces de Leishmania et les régions."
}
},
{
"@type": "Question",
"name": "Comment prévenir la leishmaniose cutanée ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'évitement des piqûres de phlébotomes et l'utilisation de répulsifs."
}
},
{
"@type": "Question",
"name": "Les moustiquaires sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation de moustiquaires peut réduire le risque de piqûres de phlébotomes."
}
},
{
"@type": "Question",
"name": "Les vaccins contre la leishmaniose existent-ils ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin efficace contre la leishmaniose cutanée."
}
},
{
"@type": "Question",
"name": "Les traitements préventifs sont-ils disponibles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitements préventifs spécifiques, mais des mesures de protection sont recommandées."
}
},
{
"@type": "Question",
"name": "Comment réduire les habitats des phlébotomes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éliminer les eaux stagnantes et maintenir une bonne hygiène peut réduire les habitats des phlébotomes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la leishmaniose cutanée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments antimoniaux, l'amphotéricine B et des thérapies locales."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont généralement efficaces, mais la réponse peut varier selon le patient."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des douleurs abdominales et des réactions allergiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option de traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie peut être envisagée pour retirer des lésions cutanées persistantes."
}
},
{
"@type": "Question",
"name": "Les traitements préventifs existent-ils ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement préventif spécifique, mais des mesures de protection sont recommandées."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections secondaires et des cicatrices permanentes."
}
},
{
"@type": "Question",
"name": "La leishmaniose cutanée peut-elle évoluer vers une forme viscérale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rarement, mais une leishmaniose cutanée peut évoluer vers une forme viscérale dans certains cas."
}
},
{
"@type": "Question",
"name": "Les cicatrices sont-elles fréquentes après traitement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des cicatrices peuvent rester après la guérison des lésions cutanées."
}
},
{
"@type": "Question",
"name": "Les infections secondaires sont-elles courantes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections bactériennes secondaires peuvent survenir sur les lésions cutanées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des impacts psychologiques liés à la maladie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les lésions cutanées peuvent entraîner des impacts psychologiques comme l'anxiété et la dépression."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent la pauvreté, l'exposition à des zones endémiques et un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées, comme celles vivant avec le VIH, sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les voyageurs sont-ils à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs se rendant dans des zones endémiques courent un risque accru."
}
},
{
"@type": "Question",
"name": "Les conditions environnementales influencent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions comme l'humidité et la chaleur favorisent la prolifération des phlébotomes."
}
},
{
"@type": "Question",
"name": "Les populations rurales sont-elles plus touchées ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les populations rurales vivant près des habitats des phlébotomes sont plus touchées."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 25/04/2026
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Medical Microbiology, Harran University Medical Faculty, Şanlıurfa 63000, Turkey.
Publications dans "Leishmaniose cutanée" :
3 publications dans cette catégorie
Affiliations :
Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, Spain. Electronic address: isabel.abadiasg@gmail.com.
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, Şanlıurfa Training and Research Hospital, Yenice Road, Yenice, Şanlıurfa 63000, Turkey.
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, Chaim Sheba Medical Center, Tel Hashomer, The Sackler School of Medicine, Tel Aviv University, Tel Aviv 8436322, Israel.
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
Center for Geographic Medicine and Tropical Diseases, Chaim Sheba Medical Center, Tel Hashomer, The Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi TÜBİTAK Biyoterapi Araştırma ve Geliştirme Laboratuvarı, İstanbul, Türkiye
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Tıbbi Mikrobiyoloji Anabilim Dalı, İstanbul, Türkiye
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, Akdeniz University, School of Medicine, Antalya, Turkey.
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
Department of Social Medicines, Qazvin University of Medical Sciences, Qazvin, Iran.
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
Esfahan Health Research Station, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
Department of Parasitology and Mycology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Entomology and Vector Control, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Entomology and Vector Control, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Publications dans "Leishmaniose cutanée" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Entomology and Vector Control, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Publications dans "Leishmaniose cutanée" :
Cutaneous Leishmaniasis (CL) is caused by protozoan parasite called Leishmania. It is endemic in more than 100 countries globally. Despite its vast prevalence and impact on quality of life, it is one ...
The data that were related to quality of life were collected using Standard one-week Dermatology Life Quality Index (DLQI) questionnaire. The questions were categorized under seven domains: symptoms &...
The lives of the majority of CL patients (60.7%) were significantly affected by CL. The quality of life of patients was moderately impacted by CL in 25% of the CL patients. In 32.1% of the CL patients...
The Dermatology Life Quality Index demonstrates that CL has a small to extremely very large negative effect on the quality of life of patients....
Species associated with visceral leishmaniasis, such as L. infantum, may be responsible for cutaneous leishmaniasis (CL), particularly in the Mediterranean region. In immunosuppressed hosts, classific...
Cutaneous leishmaniasis (CL) is a skin infection caused by various species of the Leishmania parasite and is spread by the bite of an infected female sandfly. In southern Israel, CL caused by Leishman...
To evaluate, using spatial analysis, the occurrence of American Cutaneous Leishmaniasis (ACL) and analyze its association with the municipal human development index (MHDI) and deforestation in the sta...
This ecological study, carried out from January 2016 to December 2020, included the 62 municipalities of the state of Amazonas. The incidence rate of ACL was determined in space and time. Using Multip...
A total of 7,499 cases of ACL were registered in all 62 municipalities in the state. Most cases were in male (n=5,924; 79.24%), with the greatest frequency in the population aged from 20 to 39 years (...
The occurrence of ACL was evident in a variety of patterns in the state of Amazonas; the high incidence rates and persistence of this disease in this state were linked to deforestation. The temporal d...
Cutaneous leishmaniasis (LC) is an infectious vector-borne disease caused by parasites belonging to the genus Leishmania. Metallic nanoparticles (MNPs) have been investigated as alternatives for the t...
The databases used were MEDLINE/ PubMed, Scopus, Web of Science, Embase, and Science Direct. Manual searches of the reference lists of the included studies and grey literature were also performed. Eng...
A total of 93 articles were included. Silver nanoparticles are the most studied MNPs, and L. tropica is the most studied species. Among the mechanisms of action of MNPs in vitro, we highlight the prod...
MNPs may be considered a promising alternative for the treatment of LC, but further studies are needed to define their efficacy and safety....
This systematic review evaluated the efficacy and safety of photodynamic therapy (PDT) in the management of cutaneous leishmaniasis (CL). The electronic search for identification of relevant studies, ...
To systematically review the efficacy of photodynamic therapy (PDT) in the treatment of cutaneous leishmaniasis (CL)....
PubMed, Embase and Cochrane Library databases were searched for articles published by November 16, 2022, with no time restrictions. 'Cutaneous leishmaniasis' and 'photodynamic therapy' were searched u...
(i) Randomized control trials; (ii) controlled clinical trials; (iii) case series; (iv) case reports; (v) participants were humans; (vi) clinical diagnosis was CL; (vii) treatment method used was PDT;...
In total, 303 articles were identified, including 14 papers meeting the criteria. The number of patients in each study ranged from 1 to 60 and the age ranged from 1 to 82 years. Aminolevulinic acid an...
The present study suggests that PDT is a safe and effective method for the treatment of CL, with tolerable side effects and good efficacy. As an alternative treatment method of CL, PDT has great poten...
A recent study detected cutaneous leishmaniasis (CL) in 31.9% of persons with skin ulcers in the Oti Region of Ghana, resulting in a need to investigate other potential causes of the unexplained skin ...
A community based cross-sectional study was conducted in the Oti region to investigate skin ulcers of undetermined aetiologies. To confirm a diagnosis of cutaneous leishmaniasis, Buruli ulcer, Haemoph...
This study detected single and mixed occurrence of the causative organisms of CL, yaws, and H. ducreyi cutaneous ulcers in CL endemic communities of the Oti Region in Ghana. These findings emphasize t...
Cutaneous Leishmaniasis (CL) affects millions of people globally and has a significant impact on morbidity and mortality. Innate immune mediators are likely to influence the clinical phenotype of CL t...
The cutaneous leishmaniasis (CL) incubation period (IP) is defined as the time between parasite inoculation by sandfly bite and the onset of the first CL lesion. IP distribution is difficult to assess...
We estimated CL incubation period distribution using time-to-event models adapted to interval-censored data based on declared date of travels from symptomatic military personnel living in non-endemic ...
A total of 180 patients were included, of which 176 were men (97.8%), with a median age of 26 years. When recorded, the parasite species was always Leishmania guyanensis (31/180, 17.2%). The main peri...
This work suggests that the CL IP distribution in French Guiana is shorter and more restricted than anticipated. As the incidence of CL in FG usually peaks in January and March, these findings suggest...